20160808-WHO-WHO_Library_Cataloguing-in-Publication_Data_88页_8mb

Summary of the WHO Global Report on Diabetes

Core Content

The World Health Organization (WHO) Global Report on Diabetes provides a comprehensive overview of the global burden of diabetes, its prevention and management, and the challenges in addressing it. The report emphasizes that diabetes is no longer confined to high-income countries and is now a growing public health concern worldwide, particularly in middle-income countries.

Main Points

Global Burden of Diabetes

• In 2014, an estimated 422 million adults had diabetes, compared to 108 million in 1980.
• The global prevalence of diabetes (age-standardized) nearly doubled from 4.7% to 8.5% in adults since 1980.
• 43% of diabetes-related deaths occur before the age of 70, with a higher proportion in low- and middle-income countries.
• Type 2 diabetes accounts for the majority of cases, and it is now also seen in children.
• Diabetes caused 1.5 million deaths in 2012, and higher-than-optimal blood glucose contributed to 2.2 million additional deaths due to cardiovascular and other diseases.

Complications of Diabetes

• Diabetes can lead to serious complications, including heart attacks, strokes, kidney failure, leg amputations, vision loss, and nerve damage.
• Poorly controlled diabetes during pregnancy increases the risk of fetal death, congenital malformations, and maternal complications.
• Uncontrolled diabetes is associated with increased cancer rates, physical and cognitive disability, and longer years lived with the disease.

Economic Impact

• The annual direct cost of diabetes globally is estimated at over US$827 billion.
• Health-care spending on diabetes more than tripled between 2003 and 2013.
• Analogue insulins and branded medicines contribute to rising costs, despite limited evidence of their superiority over cheaper generic alternatives.
• Catastrophic medical expenditure is more common among people with diabetes, especially in low- and middle-income countries.
• The global GDP loss from diabetes between 2011 and 2030 is estimated at US$1.7 trillion, with US$900 billion in high-income and US$800 billion in low- and middle-income countries.

Prevention and Control Strategies

Preventing Diabetes

• Type 1 diabetes is currently not preventable.
• Type 2 diabetes can be prevented through population-wide interventions such as:
  • Promoting healthy diets and physical activity.
  • Avoiding smoking and controlling blood pressure and lipids.
• A life-course approach is recommended to prevent obesity and type 2 diabetes, especially in early childhood.
• Fiscal policies, legislation, and awareness campaigns are effective in promoting healthier diets and physical activity.

Managing Diabetes

• Early diagnosis is critical for improving outcomes.
• Basic diagnostics, such as blood glucose testing, should be widely available in primary health-care settings.
• Integrated management of diabetes with cardiovascular disease, tuberculosis, and HIV/AIDS can improve care efficiency.
• Cost-effective interventions include:
  • Blood glucose control through diet, physical activity, and medication.
  • Blood pressure and lipid management to reduce cardiovascular risk.
  • Regular screening for eye, kidney, and foot damage.
• Standards and protocols are essential for improving diagnosis and management in primary care.

National Capacity for Prevention and Control

• National diabetes policies are reported in most countries, but implementation and funding are often lacking in lower-income regions.
• Primary health-care practitioners in low-income countries frequently lack basic technologies for diabetes management.
• Only one in three low- and middle-income countries has general availability of essential diabetes technologies.
• Blood glucose measurement is underrepresented in national surveys.

Access to Essential Medicines

• Insulin and oral hypoglycaemic agents are not widely available in low-income countries.
• Essential medicines for blood pressure and lipid control are often unavailable.
• Equitable access to affordable medicines and technologies is critical for effective diabetes management.

Key Recommendations

• Establish national mechanisms for multisectoral diabetes response.
• Build health ministry capacity to lead and implement diabetes strategies.
• Set national targets and indicators for accountability.
• Promote breastfeeding and healthy diets, while discouraging unhealthy foods like sugary beverages.
• Strengthen health systems to ensure accessible and affordable care.
• Develop diabetes registries and monitoring systems for better data collection and analysis.
• Address gaps in diabetes knowledge and evaluate the impact of interventions on quality of life.

Conclusion

• Diabetes is a major public health challenge with serious health and economic consequences.
• Coordinated, multicomponent interventions are essential for halting its rise and improving outcomes.
• Governments, health providers, people with diabetes, and other stakeholders must work together to achieve sustainable control and reduce the global burden of diabetes.